|
Long-term safety of sorafenib in advanced renal cell carcinoma: Follow-up of ... - UroToday |
|
|
|
UroTodayThe phase III Treatment Approaches in Renal cancer Global Evaluation Trial (TARGET) indicated that sorafenib is effective and well tolerated in advanced ... |
|
Pediatric urinary tract infections: An analysis of hospitalizations, charges ... - UroToday |
|
|
|
UroTodayDivision of Nephrology, Department of Pediatrics, Research Institute at the Nationwide Children's Hospital, Ohio State University, 700 Children's Drive, ... |